Question follow-through · 62442
Alzheimer's Disease: Donanemab and Lecanemab
To ask the Secretary of State for Health and Social Care, what discussions he has had with NICE on its decision not to recommend the use of donanemab and lecanemab for Alzheimer's patients by the NHS.
About this written question
A written question asks a government minister for information in writing. Parliament publishes the question and any answer.
- Answering body
- Department of Health and Social Care
- Tabled
- 24 Jun 2025
- Target answer date
- 26 Jun 2025
- Answer
- 1 Jul 2025 · 7 calendar days after tabling
Elapsed calendar days describe the record timeline, not whether Parliament considers an answer on time.
More questions by this MP on Health and care
- Medical Equipment: Standards · 1 Jul 2025
- Hospitals: Standards · 10 Oct 2025
- Parkinson’s Disease: Health Services · 10 Nov 2025
- Influenza: Health Services · 14 Nov 2025
- NHS: Staff · 3 Feb 2026
Shared topic keywords suggest a connection; they do not establish a follow-up.
Votes on this topic
- Terminally Ill Adults (End of Life) Bill: Second Reading · 11 Sept 2026
- Health Bill: Report Stage: Amendment 1 · 8 Sept 2026
- Health Bill: Report Stage: New Clause 143 · 8 Sept 2026
These Commons divisions share a topic label. The question did not necessarily lead to a vote.
Recorded timeline
24 Jun 2025
Question tabled
To ask the Secretary of State for Health and Social Care, what discussions he has had with NICE on its decision not to recommend the use of donanemab and lecanemab for Alzheimer's patients by the NHS.
26 Jun 2025
Target answer date
Date supplied by the official written-questions record.
1 Jul 2025
Answer published
Department officials regularly discuss a range of issues with colleagues in the National Institute for Health and Care Excellence (NICE), including the progress of specific appraisals. NICE develops its guidance independently in line with its established ...
Official data retrieved 28 Sept 2026.
Later records
Possible follow-up questions
Strong links require the same MP, department and exact heading. Other same-department questions are shown as unreviewed candidates, not as confirmed follow-ups. No debate link is asserted unless a stable source relationship exists.
Medical Equipment: Standards
1 Jul 2025 · To ask the Secretary of State for Health and Social Care, whether his Department plans to adopt the provisions set out in Annex XVI of Regulation (EU) 2017/745 on products without an intended medical purpose.
Hospitals: Standards
10 Oct 2025 · To ask the Secretary of State for Health and Social Care, what steps he is taking to help prevent patients being treated in (a) corridors, (b) converted office spaces, (c) gyms and (d) other inappropriate spaces in winter 2025-26.
Parkinson’s Disease: Health Services
10 Nov 2025 · To ask the Secretary of State for Health and Social Care, what steps his Department is taking to help improve access to (a) specialist healthcare, (b) information at diagnosis and (c) financial support for people living with Parkinson’s disease.
Influenza: Health Services
14 Nov 2025 · To ask the Secretary of State for Health and Social Care, what assessment his Department has made of the potential impact of the early flu season on (a) corridor care, (b) hospital capacity and (c) patient outcomes.
NHS: Staff
3 Feb 2026 · To ask the Secretary of State for Health and Social Care, what discussions he has had with stakeholders on his Department's modelling of workforce numbers in the 10 Year Workforce Plan.
Breast Cancer: Research
27 Feb 2026 · To ask the Secretary of State for Health and Social Care, whether he has had recent discussions with UK Research and Innovation on increasing funding for research into invasive lobular breast cancer.
Prostate Cancer: Screening
18 Mar 2026 · To ask the Secretary of State for Health and Social Care, if he will hold discussions with the devolved administrations to assess the potential merits of introducing a UK-wide screening programme for prostate cancer.
Insulin
13 May 2026 · To ask the Secretary of State for Health and Social Care, what assessment he has made with the devolved Administrations of the resilience of the UK’s insulin supply chain; and whether his Department has assessed the potential merits of supporting increase
Cancer: Research
14 Sept 2026 · To ask the Secretary of State for Health and Social Care, for (a) brain cancer, (b) breast cancer, (c) lung cancer, (d) bowel cancer and (e) prostate cancer research since 2018, what amount and what percentage of reported public research expenditure consi